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Objectives: Although there are important studies regarding the different 
carbapenemase (CARB)-producing Gram-negative bacteria, little is known 
concerning their molecular epidemiology in Portugal. The main aim of this study 
was to characterize, by phenotype and molecular typing methods, CARB-
producing Enterobacteriaceae isolates recovered from Portuguese health care 
institutions, and evaluate its impact on treatment strategy. 
 
Methods: This study included 2105 clinical isolates, collected between 
April/2006 and February/2013, in different Portuguese healthcare institutions. 
Screening of antimicrobial susceptibility was performed by disc diffusion 
method. Clinical isolates with resistance or with decreased susceptibility to 
ertapenem were considered presumptively CARB-producers; in these isolates, 
PCR and sequencing were applied to detect and identify CARB-encoding 
genes, as well as other bla and plasmid-mediated quinolone resistance 
(PMQRs) genes. MICs of CARB-producing isolates were tested by microdilution 
(EUCAST breakpoints). The plasmids obtained from clinical isolates were 
characterized by PCR-based replicon typing (PBRT). Clonal relatedness of K. 
pneumoniae isolates was investigated by multilocus sequence typing (MLST), 
using the protocol developed by the Institute Pasteur 
(www.pasteur.fr/mlst/Kpneumoniae.html). 
 
Results: Among the 2105 isolates tested, 165 (7.8%) were putative CARB-
producers and were selected for further analysis. Thirty-five (21.2%) of the 165 
positive isolates were confirmed to be CARB-producers, of which the majority 
were collected from the urine (54.3%) of elderly (≥65 years old) male patients 
(54.3%), and admitted at the emergency room/ambulatory (22.9%) or internal 
medicine (17.1%) wards. All were multidrug-resistant, with nonsusceptibility to 
at least one carbapenem, and with consistent susceptibility only to colistin. In 
those isolates was detected the following beta-lactamases: 30 KPC-3 (22 K. 
pneumoniae, 3 Escherichia coli, 2 Enterobacter aerogenes and 3 Enterobacter 
clocae), 4 GES-5 (K. pneumoniae) and one VIM-2 (Klebsiella oxytoca). CARB-
encoding genes were present alone or in combination with other bla genes, 
such as blaSHV-12, blaSHV-14, blaSHV-26, blaSHV-36, blaCTX-M-15, and the blaSHV-164. 
PMQR-encoding genes were also detected, namely qnrA, qnrB, aac(6’)-Ib-cr 
and the recently identified oqxAB. All blaKPC-3 genes were located on a Tn3-
based transposon, Tn4401, while blaGES-5 and blaVIM-2 genes were associated 
with class 3 and 1 integrons, respectively. In our study, the majority of the 
blaCARB-harbouring plasmids were nonconjugative, having been typed as 
IncFrepB by PBRT. Clonal relatedness of the 26 K. pneumoniae isolates, 
obtained by MLST, showed that they were from distinct STs, namely ST14, 
ST15, ST34, ST59, ST147, ST416, ST698, and from the two novels ST: ST960 
and, among all,  the predominant ST1138 (corresponding to KPC-3 plus SHV-
36 producers).  
 
Conclusion: In conclusion, this study provides new data regarding the 
molecular epidemiology of CARB-producing Enterobacteriaceae, which appears 
to be widespread in Portugal. Dissemination of blaCARB seems to be due to 
carriage of similar CARB-harbouring plasmids within genetically diverse clinical 
strains. Overall, our results emphasize the need of a concerted action to 
manage carbapenem use.  
 
 
